[Action of a benzodiazepine derivative, RO 5-4023. Longitudinal clinico-electroencephalographic study in epileptic patients].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D001552:Benzazepines / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D004569:Electroencephalography; D004827:Epilepsy / Q000188:drug therapy*; D004832:Epilepsy, Absence / Q000188:drug therapy; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008607:Intellectual Disability / Q000150:complications; D007659:Ketones / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009574:Nitro Compounds / Q000008:administration & dosage / Q000627:therapeutic use
D001552:Benzazepines; D007659:Ketones; D009574:Nitro Compounds
Acción del derivado benzodiazepínico RO 5-4023. Estudio clinicoelectroence falográfico longitudinal en pacientes epilépticos.